FNY Investment Advisers LLC purchased a new stake in The Allstate Corporation (NYSE:ALL – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,333 shares of the insurance provider’s stock, valued at approximately $268,000.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Arlington Trust Co LLC boosted its holdings in Allstate by 261.8% in the second quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 89 shares during the last quarter. Hughes Financial Services LLC purchased a new position in Allstate in the first quarter valued at about $28,000. Hilltop National Bank purchased a new position in Allstate in the second quarter valued at about $34,000. Meeder Asset Management Inc. boosted its holdings in Allstate by 113.8% in the first quarter. Meeder Asset Management Inc. now owns 186 shares of the insurance provider’s stock valued at $39,000 after purchasing an additional 99 shares during the last quarter. Finally, McClarren Financial Advisors Inc. purchased a new position in Allstate in the first quarter valued at about $43,000. Hedge funds and other institutional investors own 76.47% of the company’s stock.
Allstate Stock Up 0.5%
Shares of Allstate stock opened at $194.63 on Thursday. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.37. The business’s 50 day simple moving average is $204.82 and its 200-day simple moving average is $200.79. The stock has a market capitalization of $51.29 billion, a price-to-earnings ratio of 9.15, a PEG ratio of 0.70 and a beta of 0.38. The Allstate Corporation has a twelve month low of $176.00 and a twelve month high of $215.70.
Analyst Ratings Changes
Several brokerages have issued reports on ALL. Barclays restated an “underweight” rating and set a $198.00 price objective (up previously from $188.00) on shares of Allstate in a research note on Thursday, July 31st. Wolfe Research upgraded Allstate to a “strong-buy” rating in a research note on Tuesday, September 16th. Roth Capital set a $230.00 price objective on Allstate and gave the company a “buy” rating in a research note on Friday, September 26th. Evercore ISI set a $233.00 price objective on Allstate and gave the company an “in-line” rating in a research note on Wednesday, October 1st. Finally, JPMorgan Chase & Co. upped their price objective on Allstate from $235.00 to $254.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $234.60.
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories
- Five stocks we like better than Allstate
- What is the S&P/TSX Index?
- Archer’s Recent String of Victories Signals a New Phase of Growth
- How to Use the MarketBeat Stock Screener
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
- What Are Some of the Best Large-Cap Stocks to Buy?
- The Best AI for Picking Stocks, Ranked by Performance
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.